Select your country SOLUTIONS KNOWLEDGE ABOUT SAVINGS IN CARCASS CONDEMNATIONS: ~$175,000 (USD) FIND OUT MORE CELEBERATING 10 YEARS OF PROTECTION ©2017 Merial. All rights reserved. VAXXITEK is a registered trademark of Merial in the United States of America and elsewhere. Merial is now part of Boehringer Ingelheim.

Select your country SOLUTIONS KNOWLEDGE ABOUT GLOBAL PRESENCE REGISTERED AND COMMERICALLY AVAILABLE IN 75+ COUNTRIES MANUFACTURING: GAINESVILLE (U.S.A.) LYON, PORTE DES ALPES (FRANCE) NANCHANG (CHINA) HEADQUARTERS: LYON, FRANCE VTS COMPETENCE CENTERS: GAINESVILLE (U.S.A.) KUALA LUMPUR (MALAYSIA) NANTES (FRANCE) MEXICO CITY (MEXICO) CAMPINAS (BRAZIL) VACCINE PRODUCTION VAXXITEK HVT + IBD is manufactured at three Merial sites—Gainesville, Georgia, U.S.A.; Lyon, Porte des Alpes, France; and Nanchang, China—all specializing in the production of vaccines. This geographical distribution of facilities allows us to reliably supply global markets with the vaccine, maintaining optimal control over transport and storage to protect the integrity of the cold chain for this frozen product. Biologics Manufacturing in Action Merial has long been an industry leader in developing and manufacturing animal biologicals—have a look at some of our advanced techniques and technologies... WATCH NOW HISTORY & DEVELOPMENT First launched in Brazil in 2006, today a vaccine product sold under the VAXXITEK® HVT + IBD trade name is available in more than 75 countries around the world. Its development emerged from an effort to simplify the IBD vaccination process, eliminate the need to calculate timing of vaccination dates, and reduce labor in the field. OUR SCIENTISTS SPEAK Listen to members of the R&D team behind VAXXITEK HVT + IBD explain the evolution of this innovative advanced vector vaccine... WATCH NOW GLOBAL PRESENCE REGISTERED AND COMMERICALLY AVAILABLE IN 75+ COUNTRIES MANUFACTURING: GAINESVILLE (U.S.A.) LYON, PORTE DES ALPES (FRANCE) NANCHANG (CHINA) HEADQUARTERS: LYON, FRANCE VTS COMPETENCE CENTERS: GAINESVILLE (U.S.A.) KUALA LUMPUR (MALAYSIA) NANTES (FRANCE) MEXICO CITY (MEXICO) CAMPINAS (BRAZIL) GLOBAL PRESENCE VACCINE PRODUCTION HISTORY & DEVELOPMENT ABOUT VAXXITEK® HVT + IBD A single dose for strong protection against Marek's disease and IBD—in 65+ scientific papers published to date, protection was demonstrated against many different classic, variant, and very virulent IBD strains.* DOWNLOAD BROCHURE LEARN MORE ©2017 Merial. All rights reserved. VAXXITEK is a registered trademark of Merial in the United States of America and elsewhere. Merial is now part of Boehringer Ingelheim.